Suppr超能文献

舒林酸诱发的混合性结缔组织病无菌性脑膜炎。

Sulindac-induced aseptic meningitis in mixed connective tissue disease.

作者信息

Yasuda Y, Akiguchi I, Kameyama M

机构信息

Department of Neurology, Kyoto City Hospital, Japan.

出版信息

Clin Neurol Neurosurg. 1989;91(3):257-60. doi: 10.1016/0303-8467(89)90121-2.

Abstract

A 21-year-old female with mixed connective tissue disease (MCTD) experienced nausea, headache, consciousness disturbance, nuchal rigidity, and a temperature of 38.5 less than or equal to C three days after the intake of sulindac (300 mg/day). Cerebrospinal fluid analysis revealed an opening pressure of 310 mm of water, a predominantly lymphocytic pleocytosis, and elevated protein content of 89 mg/dl. After discontinuing sulindac, the aseptic meningitis improved in five days. In the acute stage, CT scan disclosed contrast enhancement in the cerebral hemispheres, which suggests that hypersensitivity may be involved in the pathogenesis of nonsteroidal antiinflammatory drug (NSAID) induced aseptic meningitis.

摘要

一名21岁混合性结缔组织病(MCTD)女性患者,在服用舒林酸(300毫克/天)三天后,出现恶心、头痛、意识障碍、颈项强直,体温达38.5摄氏度。脑脊液分析显示初压为310毫米水柱,以淋巴细胞为主的细胞增多,蛋白含量升高至89毫克/分升。停用舒林酸后,无菌性脑膜炎在五天内好转。急性期CT扫描显示大脑半球有强化表现,这提示超敏反应可能参与了非甾体抗炎药(NSAID)所致无菌性脑膜炎的发病机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验